Clinical Trial Update: Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of plinabulin with radiation and immunotherapy in select advanced cancers after progression on PD-1/PD-L1 therapy was terminated, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Melanoma
• Merkel Cell Carcinoma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Plinabulin (plinabulin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-03-18